6 hrs ago
Eli Lilly and Coverage Initiated by Analysts at Deutsche Bank
The firm set a "buy" rating on the stock. Several other analysts have also recently commented on the stock.
Tue Aug 12, 2014
Eli Lilly and Target of Unusually High Options Trading
Eli Lilly and was the target of some unusual options trading on Tuesday. Stock investors purchased 4,883 call options on the stock, StockRatingsNetwork reports.
Mon Aug 11, 2014
Eli Lilly and Price Target Cut to $61.00 by Analysts at Jefferies Group
Jefferies Group's price objective indicates a potential upside of 0.03% from the company's current price.
Wed Aug 06, 2014
Analysts' Recent Ratings Updates for Eli Lilly and
Eli Lilly and had its price target raised by analysts at Argus from $64.00 to $72.00.
Sat Aug 02, 2014
Citigroup Inc. Downgrades Eli Lilly and to Neutral
They currently have a $68.00 target price on the stock, up from their previous target price of $60.00.
Fri Aug 01, 2014
Eli Lilly and Given New $60.00 Price Target at Morgan Stanley
Morgan Stanley's price objective would suggest a potential downside of 1.12% from the stock's previous close.
Wed Jul 30, 2014
Insider Selling: Eli Lilly and major shareholder Sells 250,000 Shares of Stock
Eli Lilly and major shareholder Lilly Endowment Inc sold 250,000 shares of Eli Lilly and stock in a transaction dated Tuesday, July 29th.